US Map / Virginia
State VA

Clinical Trials in Virginia

Recruiting clinical trials with at least one study location in Virginia. Data updated daily from ClinicalTrials.gov.

Total Trials
287
Recruiting Now
287
← Back to US Map
Top Conditions in Virginia
Breast Cancer (8)Advanced Solid Tumor (7)Prostate Cancer (6)Advanced Solid Tumors (6)Non Small Cell Lung Cancer (5)NSCLC (5)Colorectal Cancer (5)Endometrial Cancer (4)Ovarian Cancer (4)Diabetic Macular Edema (4)Non-Small Cell Lung Cancer (4)Cervical Cancer (3)

Frequently Asked Questions — Clinical Trials in Virginia

How many clinical trials are currently recruiting in Virginia?
ClinicalMetric currently tracks 287 actively recruiting clinical trials with at least one location in Virginia. The total number of registered studies—including active but not currently enrolling trials—is 287. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Virginia?
Virginia hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Virginia?
To join a clinical trial in Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Virginia

NCT05929768 Phase 3
Recruiting
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple N...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
2,400 pts
Location
United States, Mexico, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05337098 N/A
Recruiting
Non-Nutritive Sweetener Consumption and Glucose Homeostasis in Older Adults With...
Condition
Continuous Glucose Monitoring
Enrollment
30 pts
Location
United States
Sponsor
Virginia Polytechnic Institute
View Trial →
NCT04104776 Phase 1, Phase 2
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumor...
Condition
Advanced Solid Tumor
Enrollment
275 pts
Location
United States, France, Italy
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06346392 Phase 3
Recruiting
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Seco...
Condition
Gastric Cancer
Enrollment
572 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
View Trial →
NCT04005976 N/A
Recruiting
Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic D...
Condition
Aortic Aneurysm
Enrollment
5,000 pts
Location
United States, Australia, Belgium
Sponsor
The University of Texas Health
View Trial →
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
View Trial →
NCT06515990 Phase 1
Recruiting
A Study of DM005 in Patients With Advanced Solid Tumors
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
136 pts
Location
United States, Australia
Sponsor
Doma Biopharmaceutical(Suzhou)
View Trial →
NCT06952660 Phase 4
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic C...
Condition
Cervical Cancer
Enrollment
100 pts
Location
United States, Puerto Rico
Sponsor
Pfizer
View Trial →
NCT07095452 Phase 2, Phase 3
Recruiting
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous...
Condition
Multiple Myeloma
Enrollment
660 pts
Location
United States, France, Japan
Sponsor
AbbVie
View Trial →
NCT06498960 N/A
Recruiting
Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in No...
Condition
Normal Pressure Hydrocephalus
Enrollment
230 pts
Location
United States, Argentina, Canada
Sponsor
CereVasc Inc
View Trial →
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
View Trial →
NCT07446439 Phase 3
Recruiting
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1...
Condition
Nausea and Vomiting
Enrollment
280 pts
Location
United States
Sponsor
Vanda Pharmaceuticals
View Trial →
NCT06590467 N/A
Recruiting
Abbott Structural Heart Device Registry
Condition
Heart Diseases
Enrollment
2,500 pts
Location
United States, Denmark, Estonia
Sponsor
Abbott Medical Devices
View Trial →
NCT04729114 Phase 1
Recruiting
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Ca...
Condition
Prostate Cancer
Enrollment
174 pts
Location
United States, Puerto Rico
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT05285553 N/A
Recruiting
MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms
Condition
Myopia
Enrollment
900 pts
Location
United States
Sponsor
CooperVision, Inc.
View Trial →
NCT07553637 Phase 2
Recruiting
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Condition
Treatment-resistant Depression (TRD)
Enrollment
178 pts
Location
United States, United Kingdom
Sponsor
Alto Neuroscience
View Trial →
NCT06589804 Phase 3
Recruiting
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatme...
Condition
Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment
158 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05064709 N/A
Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Condition
Heart Failure
Enrollment
1,500 pts
Location
United States
Sponsor
Impulse Dynamics
View Trial →
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
View Trial →
NCT06108050 Phase 1
Recruiting
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in...
Condition
Advanced Solid Tumor
Enrollment
177 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
View Trial →
NCT07223840 Phase 2
Recruiting
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid R...
Condition
Smoking
Enrollment
222 pts
Location
United States, China, Japan
Sponsor
Eli Lilly and Company
View Trial →
NCT07213817 Phase 1, Phase 2
Recruiting
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Im...
Condition
Locally Advanced Solid Tumor
Enrollment
114 pts
Location
United States, France, Spain
Sponsor
Ipsen
View Trial →
NCT04657068 Phase 1, Phase 2
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Condition
Advanced Cancer
Enrollment
442 pts
Location
United States, France, Spain
Sponsor
Artios Pharma Ltd
View Trial →
NCT04715178 N/A
Recruiting
Beat Childhood Cancer Specimen Banking and Data Registry
Condition
Pediatric Cancer
Enrollment
1,000 pts
Location
United States
Sponsor
Giselle Sholler
View Trial →
NCT05183035 Phase 3
Recruiting
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Condition
Acute Myeloid Leukemia
Enrollment
130 pts
Location
United States, Australia, Austria
Sponsor
PedAL BCU, LLC
View Trial →
Page 1 of 12 — 287 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology